{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:27:07Z","timestamp":1793608027205,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Committee","doi-asserted-by":"publisher","award":["ZDSYS20230626091203007"],"award-info":[{"award-number":["ZDSYS20230626091203007"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","award":["SYSU-58000-20220902-0001"],"award-info":[{"award-number":["SYSU-58000-20220902-0001"]}],"id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271786"],"award-info":[{"award-number":["82271786"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129118","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T06:32:03Z","timestamp":1788589923000},"page":"129118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Secretory expression of tetrameric neuraminidase enhanced by signal peptide optimization elicits robust immunity against influenza infection in mice"],"prefix":"10.1016","volume":"92","author":[{"given":"Lisha","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianmiao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10127","key":"10.1016\/j.vaccine.2026.129118_b0005","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet (London, England)"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129118_b0010","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202115352","article-title":"Seasonality of influenza and other respiratory viruses","volume":"14","author":"Neumann","year":"2022","journal-title":"EMBO Mol Med"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129118_b0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.15585\/mmwr.mm6907a1","article-title":"Interim estimates of 2019-20 seasonal influenza vaccine effectiveness - United States, February 2020","volume":"69","author":"Dawood","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129118_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-018-0002-y","article-title":"Influenza","volume":"4","author":"Krammer","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"7965","key":"10.1016\/j.vaccine.2026.129118_b0025","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41586-023-06136-y","article-title":"A pan-influenza antibody inhibiting neuraminidase via receptor mimicry","volume":"618","author":"Momont","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129118_b0030","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41541-024-00963-4","article-title":"CircRNA based multivalent neuraminidase vaccine induces broad protection against influenza viruses in mice","volume":"9","author":"Yue","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129118_b0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006682","article-title":"A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine","volume":"13","author":"Wu","year":"2017","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129118_b0040","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02332-17","article-title":"NAction! How can neuraminidase-based immunity contribute to better influenza virus vaccines?","volume":"9","author":"Krammer","year":"2018","journal-title":"mBio"},{"issue":"13","key":"10.1016\/j.vaccine.2026.129118_b0045","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adu3344","article-title":"Neuraminidase-specific antibodies drive differential cross-protection between contemporary FLUBV lineages","volume":"11","author":"Page","year":"2025","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129118_b0050","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/s41467-022-29416-z","article-title":"Structure-based design of stabilized recombinant influenza neuraminidase tetramers","volume":"13","author":"Ellis","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.129118_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.729914","article-title":"Tetrameric neuraminidase of influenza A virus is required to induce protective antibody responses in mice","volume":"12","author":"Deng","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2026.129118_b0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fmicb.2019.00039","article-title":"Influenza virus neuraminidase structure and functions","volume":"10","author":"Mcauley","year":"2019","journal-title":"Front Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129118_b0065","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.3390\/vaccines11121828","article-title":"Challenges and opportunities in the process development of chimeric vaccines","volume":"11","author":"Chauhan","year":"2023","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129118_b0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/membranes11020155","article-title":"Membrane protein stabilization strategies for structural and functional studies","volume":"11","author":"Errasti-Murugarren","year":"2021","journal-title":"Membranes"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129118_b0075","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1089\/ars.2014.5844","article-title":"Engineering of protein folding and secretion\u2014strategies to overcome bottlenecks for efficient production of recombinant proteins","volume":"21","author":"Delic","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.vaccine.2026.129118_b0080","article-title":"A computationally optimised structural integrity sequence enhances vaccine stability, yield and safety profile","author":"Sarron","year":"2025","journal-title":"Res Sq"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129118_b0085","doi-asserted-by":"crossref","first-page":"e0224121","DOI":"10.1128\/mBio.02241-21","article-title":"A novel recombinant influenza virus neuraminidase vaccine candidate stabilized by a measles virus phosphoprotein tetramerization domain provides robust protection from virus challenge in the mouse model","volume":"12","author":"Strohmeier","year":"2021","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129118_b0090","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jbiotec.2006.11.026","article-title":"The level of synthesis and secretion of Gaussia princeps luciferase in transfected CHO cells is heavily dependent on the choice of signal peptide","volume":"128","author":"Knappskog","year":"2007","journal-title":"J Biotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129118_b0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41541-022-00435-7","article-title":"Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidase","volume":"7","author":"Catani","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"25","key":"10.1016\/j.vaccine.2026.129118_b0100","doi-asserted-by":"crossref","first-page":"11092","DOI":"10.1021\/jacs.0c03217","article-title":"Mechanism of coupled folding-upon-binding of an intrinsically disordered protein","volume":"142","author":"Robustelli","year":"2020","journal-title":"J Am Chem Soc"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129118_b0105","doi-asserted-by":"crossref","DOI":"10.3390\/biom15060897","article-title":"Signal peptides: from molecular mechanisms to applications in protein and vaccine engineering","volume":"15","author":"Zhang","year":"2025","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129118_b0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/vaccines6010007","article-title":"Development of Zika virus vaccines","volume":"6","author":"Makhluf","year":"2018","journal-title":"Vaccines"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129118_b0115","doi-asserted-by":"crossref","first-page":"e0009722","DOI":"10.1128\/aem.00097-22","article-title":"An intrinsically disordered peptide tag that confers an unusual solubility to aggregation-prone proteins","volume":"88","author":"Jo","year":"2022","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2026.129118_b0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.imlet.2017.07.007","article-title":"Tissue plasminogen activator (tPA) signal sequence enhances immunogenicity of MVA-based vaccine against tuberculosis","volume":"190","author":"Kou","year":"2017","journal-title":"Immunol Lett"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129118_b0125","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28484","article-title":"Needle-free injection system delivery of ZyCoV-D DNA vaccine demonstrated improved immunogenicity and protective efficacy in rhesus macaques against SARS-CoV-2","volume":"95","author":"Yadav","year":"2023","journal-title":"J Med Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129118_b0130","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.bbapap.2015.05.008","article-title":"Bacterial expression and re-engineering of Gaussia princeps luciferase and its use as a reporter protein","volume":"1854","author":"Wu","year":"2015","journal-title":"Biochim Biophy Acta Proteins Proteomics"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129118_b0135","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1261\/rna.080733.125","article-title":"Development of a modified RNA circularization system to improve circRNA-based protein expression in mammalian cells","volume":"31","author":"Cui","year":"2025","journal-title":"RNA"},{"key":"10.1016\/j.vaccine.2026.129118_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2026.2730071","article-title":"Redirecting NEU (neuraminidase) antigen to autophagosomes confers enhanced cross-reactive T-cell immunity against heterosubtypic influenza virus infection","author":"Han","year":"2026","journal-title":"Autophagy"},{"key":"10.1016\/j.vaccine.2026.129118_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105978","article-title":"Mosaic neuraminidase-based vaccine induces antigen-specific T cell responses against homologous and heterologous influenza viruses","volume":"230","author":"Han","year":"2024","journal-title":"Antivir Res"},{"issue":"23","key":"10.1016\/j.vaccine.2026.129118_b0150","doi-asserted-by":"crossref","first-page":"24200","DOI":"10.1021\/acsnano.3c09521","article-title":"Rapid induction of long-lasting systemic and mucosal immunity via thermostable microneedle-mediated chitosan oligosaccharide-encapsulated DNA nanoparticles","volume":"17","author":"Li","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.vaccine.2026.129118_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105383","article-title":"Rational design of AAVrh10-vectored ACE2 functional domain to broadly block the cell entry of SARS-CoV-2 variants","volume":"205","author":"Li","year":"2022","journal-title":"Antivir Res"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129118_b0160","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jinf.2010.03.005","article-title":"Induction of balance and breadth in the immune response is beneficial for the control of SIVmac239 replication in rhesus monkeys","volume":"60","author":"Sun","year":"2010","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129118_b0165","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2022.2136538","article-title":"Booster vaccination is required to elicit and maintain COVID-19 vaccine-induced immunity in SIV-infected macaques","volume":"12","author":"Li","year":"2023","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129118_b0170","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41541-023-00728-5","article-title":"A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses","volume":"8","author":"Liu","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2026.129118_b0175","first-page":"56448","article-title":"Measuring influenza neutralizing antibody responses to a (H3N2) viruses in human sera by microneutralization assays using MDCK-SIAT1 cells","volume":"129","author":"Gross","year":"2017","journal-title":"J Vis Exp JoVE"},{"key":"10.1016\/j.vaccine.2026.129118_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105269","article-title":"A broad-spectrum multiepitope vaccine against seasonal influenza a and B viruses in mice","volume":"106","author":"Yuan","year":"2024","journal-title":"EBioMedicine"},{"issue":"21","key":"10.1016\/j.vaccine.2026.129118_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111871","article-title":"Take me home, protein roads: structural insights into signal peptide interactions during ER translocation","volume":"22","author":"Liaci","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129118_b0190","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/MMBR.64.3.515-547.2000","article-title":"Signal peptide-dependent protein transport in Bacillus subtilis: a genome-based survey of the secretome","volume":"64","author":"Tjalsma","year":"2000","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.vaccine.2026.129118_b0195","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nbt.2025.10.007","article-title":"Engineering enhanced signal peptides: a high-throughput computational pipeline for optimizing therapeutic protein production in CHO cells","volume":"90","author":"Zhang","year":"2025","journal-title":"New Biotechnol"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129118_b0200","article-title":"Overcoming the refractory expression of secreted recombinant proteins in mammalian cells through modification of the signal peptide and adjacent amino acids","volume":"11","author":"G\u00fcler-G","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129118_b0205","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1432-1033.1997.00720.x","article-title":"The N-domain of the signal recognition particle 54-kDa subunit promotes efficient signal sequence binding","volume":"245","author":"Newitt","year":"1997","journal-title":"Eur J Biochem"},{"issue":"5912","key":"10.1016\/j.vaccine.2026.129118_b0210","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/303035a0","article-title":"Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 \u00c5 resolution","volume":"303","author":"Varghese","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.129118_b0215","series-title":"Influenza pathogenesis and control-volume II","first-page":"275","article-title":"Influenza neuraminidase as a vaccine antigen","author":"Eichelberger","year":"2014"},{"issue":"19","key":"10.1016\/j.vaccine.2026.129118_b0220","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.vaccine.2014.01.078","article-title":"Stability of neuraminidase in inactivated influenza vaccines","volume":"32","author":"Sultana","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129118_b0225","article-title":"Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system","volume":"81","author":"Margine","year":"2013","journal-title":"J Visual Exp JoVE"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129118_b0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016284","article-title":"A generic system for the expression and purification of soluble and stable influenza neuraminidase","volume":"6","author":"Schmidt","year":"2011","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.vaccine.2026.129118_b0235","doi-asserted-by":"crossref","first-page":"9457","DOI":"10.1128\/JVI.01346-16","article-title":"Identification of residues that affect oligomerization and\/or enzymatic activity of influenza virus H5N1 neuraminidase proteins","volume":"90","author":"Dai","year":"2016","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129118_b0240","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12951-024-02488-3","article-title":"Efficient signal sequence of mRNA vaccines enhances the antigen expression to expand the immune protection against viral infection","volume":"22","author":"Zhang","year":"2024","journal-title":"J Nanobiotechnol"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129118_b0245","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.molimm.2011.01.006","article-title":"Signal peptides and trans-membrane regions are broadly immunogenic and have high CD8+ T cell epitope densities: implications for vaccine development","volume":"48","author":"Kovjazin","year":"2011","journal-title":"Mol Immunol"},{"issue":"17","key":"10.1016\/j.vaccine.2026.129118_b0250","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1128\/JVI.00647-07","article-title":"Immunogenicity of influenza virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting cells","volume":"81","author":"Abdel-Motal","year":"2007","journal-title":"J Virol"},{"issue":"5912","key":"10.1016\/j.vaccine.2026.129118_b0255","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/303035a0","article-title":"Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution","volume":"303","author":"Varghese","year":"1983","journal-title":"Nature"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:39:22Z","timestamp":1793605162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26009278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"alternative-id":["S0264410X26009278"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129118","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secretory expression of tetrameric neuraminidase enhanced by signal peptide optimization elicits robust immunity against influenza infection in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129118"}}